• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的现状和未来负担:2020 年和 2040 年全球统计数据。

Current and future burden of breast cancer: Global statistics for 2020 and 2040.

机构信息

Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.

Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.

出版信息

Breast. 2022 Dec;66:15-23. doi: 10.1016/j.breast.2022.08.010. Epub 2022 Sep 2.

DOI:10.1016/j.breast.2022.08.010
PMID:36084384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9465273/
Abstract

BACKGROUND

Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040.

METHODS

Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040.

RESULTS

Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone.

CONCLUSION

Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high.

摘要

背景

乳腺癌是全球最常见的癌症,其负担在过去几十年中一直在上升。本文旨在研究和描述 2020 年全球乳腺癌负担,并对 2040 年的情况进行预测。

方法

从 GLOBOCAN 数据库中提取 2020 年女性乳腺癌新发病例和死亡人数的估计值。按国家、世界区域和人类发展水平计算每 10 万名女性的年龄标准化发病率和死亡率。根据 2040 年全球人口预测计算预测病例和死亡人数。

结果

2020 年全球有超过 230 万例新发病例和 68.5 万例乳腺癌死亡。国家和世界区域之间存在较大的地理差异,发病率从某些亚洲和非洲国家的每 10 万女性<40 例到澳大利亚/新西兰、北美和欧洲部分地区的每 10 万女性超过 80 例不等。死亡率的地理差异较小;然而,转型国家乳腺癌死亡的负担相对于已转型国家仍不成比例。到 2040 年,仅由于人口增长和老龄化,乳腺癌负担预计每年将增加到 300 多万例新发病例和 100 多万例死亡。

结论

乳腺癌是全球最常见的癌症,继续对全球癌症死亡人数产生重大影响。需要全球共同努力来应对其不断增加的负担,特别是在发病率迅速上升且死亡率仍然较高的转型国家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/778ffb7d63d0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/c8e3c0439ecd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/086a9ef01906/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/5184516a8de8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/778ffb7d63d0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/c8e3c0439ecd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/086a9ef01906/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/5184516a8de8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/778ffb7d63d0/gr4.jpg

相似文献

1
Current and future burden of breast cancer: Global statistics for 2020 and 2040.乳腺癌的现状和未来负担:2020 年和 2040 年全球统计数据。
Breast. 2022 Dec;66:15-23. doi: 10.1016/j.breast.2022.08.010. Epub 2022 Sep 2.
2
Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050.亚洲乳腺癌的当前及未来负担:2022年和2050年全球癌症负担数据分析
Breast. 2025 Feb;79:103835. doi: 10.1016/j.breast.2024.103835. Epub 2024 Nov 12.
3
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.2020年和2040年全球结直肠癌负担:来自全球癌症负担(GLOBOCAN)的发病率和死亡率估计
Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736. Epub 2022 Sep 8.
4
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.2020 年全球皮肤黑色素瘤负担及 2040 年预测。
JAMA Dermatol. 2022 May 1;158(5):495-503. doi: 10.1001/jamadermatol.2022.0160.
5
Global burden of gynaecological cancers in 2022 and projections to 2050.2022 年全球妇科癌症负担及 2050 年预测。
J Glob Health. 2024 Aug 16;14:04155. doi: 10.7189/jogh.14.04155.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
Global burden of primary liver cancer in 2020 and predictions to 2040.2020 年全球原发性肝癌负担及 2040 年预测。
J Hepatol. 2022 Dec;77(6):1598-1606. doi: 10.1016/j.jhep.2022.08.021. Epub 2022 Oct 5.
8
The current and future global burden of cancer among adolescents and young adults: a population-based study.青少年和青年人群中癌症的当前及未来全球负担:一项基于人群的研究。
Lancet Oncol. 2024 Dec;25(12):1614-1624. doi: 10.1016/S1470-2045(24)00523-0. Epub 2024 Nov 15.
9
Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020.全球乳腺癌发病和死亡模式:基于 2000 年至 2020 年癌症登记处数据的分析。
Cancer Commun (Lond). 2021 Nov;41(11):1183-1194. doi: 10.1002/cac2.12207. Epub 2021 Aug 16.
10
Global esophageal cancer epidemiology in 2022 and predictions for 2050: A comprehensive analysis and projections based on GLOBOCAN data.2022年全球食管癌流行病学及2050年预测:基于全球癌症数据库(GLOBOCAN)数据的综合分析与预测
Chin Med J (Engl). 2024 Dec 20;137(24):3108-3116. doi: 10.1097/CM9.0000000000003420. Epub 2024 Dec 13.

引用本文的文献

1
Association among Noncoding-RNAs, APRO Family Proteins, and Gut Microbiota in the Development of Breast Cancer.非编码RNA、APRO家族蛋白与肠道微生物群在乳腺癌发生发展中的关联
Oncol Res. 2025 Aug 28;33(9):2205-2219. doi: 10.32604/or.2025.062810. eCollection 2025.
2
Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III.黄连素通过减弱DNA连接酶III使乳腺癌细胞对辐射敏感。
J Cell Mol Med. 2025 Sep;29(17):e70836. doi: 10.1111/jcmm.70836.
3
The impact of breast cancer awareness campaigns on the knowledge, attitudes, and practices of breast cancer screening among Saudi female employees.
乳腺癌宣传活动对沙特女性雇员乳腺癌筛查知识、态度及行为的影响
PLoS One. 2025 Sep 5;20(9):e0331765. doi: 10.1371/journal.pone.0331765. eCollection 2025.
4
Arjunolic Acid From Terminalia ivorensis A. Chev (Combretaceae) Possesses Anti-Breast Cancer Effects In Vitro and In Vivo.来自象牙海岸榄仁树(使君子科)的阿朱诺酸在体外和体内均具有抗乳腺癌作用。
Cancer Rep (Hoboken). 2025 Sep;8(9):e70337. doi: 10.1002/cnr2.70337.
5
Identification of potential hub genes and molecular mechanisms in breast cancer microenvironment: A comprehensive transcriptomics approach.乳腺癌微环境中潜在枢纽基因及分子机制的鉴定:一种综合转录组学方法
Medicine (Baltimore). 2025 Aug 29;104(35):e44142. doi: 10.1097/MD.0000000000044142.
6
Human papillomavirus-related syntaxin 11 reprograms tumor-associated macrophages to induce breast cancer cell apoptosis via PI3K/AKT signaling.人乳头瘤病毒相关的 syntaxin 11 通过 PI3K/AKT 信号通路重编程肿瘤相关巨噬细胞以诱导乳腺癌细胞凋亡。
Mol Med. 2025 Sep 2;31(1):285. doi: 10.1186/s10020-025-01325-z.
7
VisR Ultrasound Improves Diagnosis of Breast Cancer by the Elastogram-to-B-Mode Ratio in a Blinded Reader Study.在一项盲法阅片者研究中,VisR超声通过弹性图与B型模式比值改善乳腺癌诊断。
IEEE Open J Ultrason Ferroelectr Freq Control. 2025;5:67-76. doi: 10.1109/ojuffc.2025.3560585. Epub 2025 Apr 14.
8
The association between neighborhood socioeconomic status and breast cancer incidence and mortality risk: a large-scale cohort studies systematic review and meta-analysis.社区社会经济地位与乳腺癌发病率和死亡率风险之间的关联:一项大规模队列研究的系统评价和荟萃分析。
Breast Cancer. 2025 Aug 30. doi: 10.1007/s12282-025-01764-w.
9
Multidimensional evaluation of 3.0T HR-MRI, ultrasound imaging, and GATA3 protein expression in breast cancer, and their prognostic analysis.3.0T高分辨率磁共振成像、超声成像及GATA3蛋白表达在乳腺癌中的多维评估及其预后分析
Front Oncol. 2025 Aug 13;15:1587243. doi: 10.3389/fonc.2025.1587243. eCollection 2025.
10
Evaluation of the Cytotoxic Activity of Nanostructured Lipid Carrier Systems for Fatty Acid Amides and Silk Fibroins in Breast Cancer Cell Lines.纳米结构脂质载体系统对乳腺癌细胞系中脂肪酸酰胺和丝素蛋白的细胞毒性活性评估
Molecules. 2025 Aug 11;30(16):3337. doi: 10.3390/molecules30163337.